PRDM proteins: Important players in differentiation and disease
Open accessThe DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Abstract
The PRDM family has recently spawned considerable interest as it has been implicated in fundamental aspects of cellular differentiation and exhibits expanding ties to human diseases. The PRDMs belong to the SET domain family of histone methyltransferases, however, enzymatic activity has been determined for only few PRDMs suggesting that they act by recruiting co‐factors or, more speculatively, confer methylation of non‐histone targets. Several PRDM family members are deregulated in human diseases, most prominently in hematological malignancies and solid cancers, where they can act as both tumor suppressors or drivers of oncogenic processes. The molecular mechanisms have been delineated for only few PRDMs and little is known about functional redundancy within the family. Future studies should identify target genes of PRDM proteins and the protein complexes in which PRDM proteins reside to provide a more comprehensive understanding of the biological and biochemical functions of this important protein family.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Maternal smoking during pregnancy was found to significantly reduce the methylation of the gene PRDM8 (PR domain contain 8), which is a gene that’s tightly regulated in a spatiotemporal manner during neural development and is important for regulating the morphological transition in neocortical development”
From Prenatal nicotine exposure during pregnancy results in adverse neurodevelopmental alterations and neurobehavioral deficits (2023) · cites this paper as [53]
Citations
Cites
Wnt/β-Catenin Signaling in Development and Disease
Clevers, H. (2006) · Cell · doi:10.1016/j.cell.2006.10.018 · Cited by 5,568 · cited 1×
“WNT signaling is crucial for many steps of early development, cell differentiation and for the homeostasis of several adult tissues, most noticeably intestinal epithelium, and defects inWNT signaling are associated with many diseases including colon cancer [95].”
Hematopoiesis: An Evolving Paradigm for Stem Cell Biology
Orkin, S. H., & Zon, L. I. (2008) · Cell · doi:10.1016/j.cell.2008.01.025 · Cited by 2,570 · cited 1×
“The latter give rise to multipotent progenitors (MPPs) capable of generating the common myeloid (CMPs) and common lymphoid (CLPs) progenitors that differentiate into immature progenitors of the various blood cell lineages [42].”
BackgroundPRDM16 controls a brown fat/skeletal muscle switch
Seale, P., Bjork, B., Yang, W., Kajimura, S., Chin, S., Kuang, S., Scimè, A., Devarakonda, S., Conroe, H. M., Erdjument-Bromage, H., et al. (2008) · Nature · doi:10.1038/nature07182 · Cited by 2,347
Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice
Seale, P., Conroe, H. M., Estall, J., Kajimura, S., Frontini, A., Ishibashi, J., Cohen, P., Cinti, S., & Spiegelman, B. M. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44271 · Cited by 1,252 · cited 6×
“Abbreviations: ABC, activated B cell-like; ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; CLL, chronic lymphocytic leukemia; CLP, common lymphoid progenitor; CML, chronic myeloid leukemia; CMP, common myeloid progenitor; DLBCL, diffuse large B cell lymphoma; ES, embryonic stem; GC, germinal center; HA…”
BackgroundInfluentialTranscriptional Control of Brown Fat Determination by PRDM16
Seale, P., Kajimura, S., Yang, W., Chin, S., Rohas, L. M., Uldry, M., Tavernier, G., Langin, D., & Spiegelman, B. M. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.06.001 · Cited by 1,174 · cited 3×
“PRDMs’ molecular mechanisms in transcriptional regulation Name Common alias HMT activity (in complex) Consensus sequence Binding partners PRDM1 BLIMP1 (Prmt5 H2AR3me2s, H4R3me2s [14]), (G9a H3K9me2 [9]) Yes [99] G9a [9], HDAC2 [13], IRF4 [100], LSD1 [15], PRMT5 [14], TLE1, TLE2 [18] PRDM2 RIZ1/2 H3K9me2 [6] ER [101],…”
BackgroundBlimp1 is a critical determinant of the germ cell lineage in mice
Ohinata, Y., Payer, B., O'Carroll, D., Ancelin, K., Ono, Y., Sano, M., Barton, S. C., Obukhanych, T., Nussenzweig, M., Tarakhovsky, A., et al. (2005) · Nature · doi:10.1038/nature03813 · Cited by 1,046 · cited 2×
“Prdm1 Blimp1 Embryonic lethal, failure of PCG formation [25] Prdm1 Lck-Cre;Blimp1”
BackgroundPRDM9 Is a Major Determinant of Meiotic Recombination Hotspots in Humans and Mice
Baudat, F., Buard, J., Grey, C., Fledel-Alon, A., Ober, C., Przeworski, M., Coop, G., & de Massy, B. (2010) · Science · doi:10.1126/science.1183439 · Cited by 1,026 · cited 9×
“PRDMs’ molecular mechanisms in transcriptional regulation Name Common alias HMT activity (in complex) Consensus sequence Binding partners PRDM1 BLIMP1 (Prmt5 H2AR3me2s, H4R3me2s [14]), (G9a H3K9me2 [9]) Yes [99] G9a [9], HDAC2 [13], IRF4 [100], LSD1 [15], PRMT5 [14], TLE1, TLE2 [18] PRDM2 RIZ1/2 H3K9me2 [6] ER [101],…”
BackgroundInfluentialRegulation of plasma-cell development
Shapiro-Shelef, M., & Calame, K. (2005) · Nature Reviews Immunology · doi:10.1038/nri1572 · Cited by 881 · cited 1×
“In addition, PRDM1 stimulates antibody secretion by (indirect) induction of XBP1, a transcription factor driving the expression of genes involved in antibody secretion [60].”
BackgroundShapiro-Shelef, M., Lin, K.-I., McHeyzer-Williams, L. J., Liao, J., McHeyzer-Williams, M. G., & Calame, K. (2003) · Immunity · doi:10.1016/s1074-7613(03)00267-x · Cited by 839 · cited 2×
“(inducible GC B cell specific CKO) Block in terminal plasma cell differentiation [56]”
BackgroundTurner, C. A., Mack, D. H., & Davis, M. M. (1994) · Cell · doi:10.1016/0092-8674(94)90321-2 · Cited by 761
Initiation of myoblast to brown fat switch by a PRDM16–C/EBP-β transcriptional complex
Kajimura, S., Seale, P., Kubota, K., Lunsford, E., Frangioni, J. V., Gygi, S. P., & Spiegelman, B. M. (2009) · Nature · doi:10.1038/nature08262 · Cited by 703
Drive Against Hotspot Motifs in Primates Implicates the PRDM9 Gene in Meiotic Recombination
Myers, S., Bowden, R., Tumian, A., Bontrop, R. E., Freeman, C., MacFie, T. S., McVean, G., & Donnelly, P. (2010) · Science · doi:10.1126/science.1182363 · Cited by 683
Rutishauser, R. L., Martins, G. A., Kalachikov, S., Chandele, A., Parish, I. A., Meffre, E., Jacob, J., Calame, K., & Kaech, S. M. (2009) · Immunity · doi:10.1016/j.immuni.2009.05.014 · Cited by 611
Critical function of Prdm14 for the establishment of the germ cell lineage in mice
Yamaji, M., Seki, Y., Kurimoto, K., Yabuta, Y., Yuasa, M., Shigeta, M., Yamanaka, K., Ohinata, Y., & Saitou, M. (2008) · Nature Genetics · doi:10.1038/ng.186 · Cited by 581 · cited 1×
“Prdm7/9 Meisetz Sterile due to a defect in meiosis [8] Prdm14 Prdm14 / Sterile due to impaired PGCs specification [26]”
BackgroundLenz, G., & Staudt, L. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0807082 · Cited by 528
Effectors and memories: Bcl-6 and Blimp-1 in T and B lymphocyte differentiation
Crotty, S., Johnston, R. J., & Schoenberger, S. P. (2010) · Nature Immunology · doi:10.1038/ni.1837 · Cited by 524 · cited 2×
“Reciprocal repression of each other by BCL6 and PRDM1 is also crucial for differentiation of T lymphocytes [61].”
BackgroundA histone H3 methyltransferase controls epigenetic events required for meiotic prophase
Hayashi, K., Yoshida, K., & Matsui, Y. (2005) · Nature · doi:10.1038/nature04112 · Cited by 472 · cited 6×
“PRDMs’ molecular mechanisms in transcriptional regulation Name Common alias HMT activity (in complex) Consensus sequence Binding partners PRDM1 BLIMP1 (Prmt5 H2AR3me2s, H4R3me2s [14]), (G9a H3K9me2 [9]) Yes [99] G9a [9], HDAC2 [13], IRF4 [100], LSD1 [15], PRMT5 [14], TLE1, TLE2 [18] PRDM2 RIZ1/2 H3K9me2 [6] ER [101],…”
BackgroundInfluentialRegulation of the brown and white fat gene programs through a PRDM16/CtBP transcriptional complex
Kajimura, S., Seale, P., Tomaru, T., Erdjument-Bromage, H., Cooper, M. P., Ruas, J. L., Chin, S., Tempst, P., Lazar, M. A., & Spiegelman, B. M. (2008) · Genes & Development · doi:10.1101/gad.1666108 · Cited by 468 · cited 4×
“PRDMs’ molecular mechanisms in transcriptional regulation Name Common alias HMT activity (in complex) Consensus sequence Binding partners PRDM1 BLIMP1 (Prmt5 H2AR3me2s, H4R3me2s [14]), (G9a H3K9me2 [9]) Yes [99] G9a [9], HDAC2 [13], IRF4 [100], LSD1 [15], PRMT5 [14], TLE1, TLE2 [18] PRDM2 RIZ1/2 H3K9me2 [6] ER [101],…”
BackgroundInfluentialBlimp1 associates with Prmt5 and directs histone arginine methylation in mouse germ cells
Ancelin, K., Lange, U. C., Hajkova, P., Schneider, R., Bannister, A. J., Kouzarides, T., & Surani, M. A. (2006) · Nature Cell Biology · doi:10.1038/ncb1413 · Cited by 464 · cited 2×
“Mechanistically, Prdm1 was shown to repress the somatic marker geneDhx38 by recruiting the Prmt5 histone arginine methyltransferase to a Prdm1 consensus element resulting in gene repression via di-methylation of histone H4 arginine 3 (H4R3me2) [14].”
BackgroundA genome-wide RNAi screen reveals determinants of human embryonic stem cell identity
Chia, N.-Y., Chan, Y.-S., Feng, B., Lu, X., Orlov, Y. L., Moreau, D., Kumar, P., Yang, L., Jiang, J., Lau, M.-S., et al. (2010) · Nature · doi:10.1038/nature09531 · Cited by 461
Transcriptional Control of Brown Fat Development
Kajimura, S., Seale, P., & Spiegelman, B. M. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.03.005 · Cited by 416 · cited 2×
“Two types of fat tissue exist in mammals: white adipose tissue (WAT), which is a fat-storage tissue and brown adipose tissue where fat is used for heat generation [30].”
BackgroundTranscriptional repressor Blimp-1 regulates T cell homeostasis and function
Martins, G. A., Cimmino, L., Shapiro-Shelef, M., Szabolcs, M., Herron, A., Magnusdottir, E., & Calame, K. (2006) · Nature Immunology · doi:10.1038/ni1320 · Cited by 372 · cited 1×
“However, extensive research has revealed that PRDM1 is involved in differentiation, maintenance and/or function of multiple cell types, including hematopoietic cells from the myeloid lineage [55] and lymphoid lineages such as plasma cells [56], T-cells [57, 58], and NK cells [59] (Fig.”
BackgroundThe oncoprotein Evi-1 represses TGF-β signalling by inhibiting Smad3
Kurokawa, M., Mitani, K., Irie, K., Matsuyama, T., Takahashi, T., Chiba, S., Yazaki, Y., Matsumoto, K., & Hirai, H. (1998) · Nature · doi:10.1038/27945 · Cited by 371
Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma
Pasqualucci, L., Compagno, M., Houldsworth, J., Monti, S., Grunn, A., Nandula, S. V., Aster, J. C., Murty, V. V., Shipp, M. A., & Dalla-Favera, R. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052204 · Cited by 370 · cited 1×
“PRDM1 has also been found to be lost in human DLBCL of the ABC-like subtype by several mechanisms including chromosomal deletion, epigenetic silencing, microRNA-mediated silencing and inactivating mutations [64, 66–68].”
BackgroundPRDI-BF1 recruits the histone H3 methyltransferase G9a in transcriptional silencing
Győry, I., Wu, J., Fejér, G., Seto, E., & Wright, K. L. (2004) · Nature Immunology · doi:10.1038/ni1046 · Cited by 334 · cited 2×
“(G9a H3K9me2 [9]) Yes [99] G9a [9], HDAC2 [13], IRF4 [100], LSD1 [15],”
BackgroundTranscriptional Repression by Blimp-1 (PRDI-BF1) Involves Recruitment of Histone Deacetylase
Yu, J., Angelin-Duclos, C., Greenwood, J., Liao, J., & Calame, K. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.7.2592-2603.2000 · Cited by 327 · cited 2×
“(G9a H3K9me2 [9]) Yes [99] G9a [9], HDAC2 [13], IRF4 [100], LSD1 [15],”
BackgroundKeep Your Fingers Off My DNA: Protein–Protein Interactions Mediated by C2H2 Zinc Finger Domains
Brayer, K. J., & Segal, D. J. (2008) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-008-9008-5 · Cited by 320 · cited 1×
“Aside from association with chromatin modifiers, PRDM proteins have been found to interact with a plethora of proteins mostly via their C2H2 zinc-fingers enabling either protein-DNA or protein-protein interaction [17].”
BackgroundBerg, I. L., Neumann, R., Lam, K.-W. G., Sarbajna, S., Odenthal-Hesse, L., May, C. A., & Jeffreys, A. J. (2010) · Nature Genetics · doi:10.1038/ng.658 · Cited by 315 · cited 1×
“Moreover, human PRDM9 shows a large degree of genetic variation giving rise to PRDM9 proteins containing 8–18 zinc fingers and this genetic variability is a key factor determining the different activities of DNA recombination hotspots [29].”
BackgroundGerm cell specification in mice
Saitou, M. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.06.003 · Cited by 298 · cited 1×
“The induction and maturation of PGCs require an extensive alteration in the gene expression program consisting of repression of the mesoderm somatic program, reacquisition of potential pluripotency and genome-wide epigenetic reprogramming [24].”
Evi-1 Is a Critical Regulator for Hematopoietic Stem Cells and Transformed Leukemic Cells
Goyama, S., Yamamoto, G., Shimabe, M., Sato, T., Ichikawa, M., Ogawa, S., Chiba, S., & Kurokawa, M. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.06.002 · Cited by 287
Mandelbaum, J., Bhagat, G., Tang, H., Mo, T., Brahmachary, M., Shen, Q., Chadburn, A., Rajewsky, K., Tarakhovsky, A., Pasqualucci, L., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.030 · Cited by 282 · cited 9×
“Abbreviations: ABC, activated B cell-like; ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; CLL, chronic lymphocytic leukemia; CLP, common lymphoid progenitor; CML, chronic myeloid leukemia; CMP, common myeloid progenitor; DLBCL, diffuse large B cell lymphoma; ES, embryonic stem; GC, germinal center; HA…”
BackgroundInfluentialStructural Biology of Human H3K9 Methyltransferases
Wu, H., Min, J., Lunin, V. V., Antoshenko, T., Dombrovski, L., Zeng, H., Allali-Hassani, A., Campagna-Slater, V., Vedadi, M., Arrowsmith, C. H., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008570 · Cited by 268 · cited 1×
“Moreover, the crystal structure of PRDM2 revealed that the two domains are also structurally similar, both being able to accommodate the co-factor S-adenosyl-methionine [2].”
BackgroundGerm Cell Specification in Mice
Hayashi, K., de Sousa Lopes, S. M. C., & Surani, M. A. (2007) · Science · doi:10.1126/science.1137545 · Cited by 254
PRDI-BF1/Blimp-1 repression is mediated by corepressors of the Groucho family of proteins
Ren, B., Chee, K. J., Kim, T. H., & Maniatis, T. (1999) · Genes & Development · doi:10.1101/gad.13.1.125 · Cited by 252 · cited 1×
“Importantly, PRDM proteins have been demonstrated to tether transcription factors to target gene promoters by recognizing a specific DNA consensus sequence, as exemplified by the PRDM1-mediated repression of the INFb promoter by recruiting the Groucho transcription factors [18], or act as non-DNA binding cofactors, as…”
BackgroundMutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas
Tam, W., Gomez, M., Chadburn, A., Lee, J. W., Chan, W. C., & Knowles, D. M. (2006) · Blood · doi:10.1182/blood-2005-09-3778 · Cited by 230 · cited 1×
“PRDM1 has also been found to be lost in human DLBCL of the ABC-like subtype by several mechanisms including chromosomal deletion, epigenetic silencing, microRNA-mediated silencing and inactivating mutations [64, 66–68].”
BackgroundPrdm16 promotes stem cell maintenance in multiple tissues, partly by regulating oxidative stress
Chuikov, S., Levi, B. P., Smith, M. L., & Morrison, S. J. (2010) · Nature Cell Biology · doi:10.1038/ncb2101 · Cited by 224 · cited 4×
“Like Prdm3, mouse studies have shown that Prdm16 is required for HSC homeostasis [39, 52] and overexpression of Prdm16 causes a decrease of apoptosis and a relative increase of HSC number in vitro and increased reconstitution ability in vivo [53].”
BackgroundInfluentialInactivation of a histone methyltransferase by mutations in human cancers.
Kim, K., Geng, L., & Huang, S. (2003) · PubMed · Cited by 221
Yuasa, H., Oike, Y., Iwama, A., Nishikata, I., Sugiyama, D., Perkins, A., Mucenski, M. L., Suda, T., & Morishita, K. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600679 · Cited by 213 · cited 1×
“Prdm3/Evi1 deficient HSCs from fetal liver lost their reconstitution capability, which appeared to involve lack of Prdm3/ Evi1-mediated transcriptional activation of Gata2 [44, 46] and a decrease of the HSC pool was also found upon inducible loss of Prdm3/Evi1 in adult mice [44].”
BackgroundSteele-Perkins, G., Fang, W., Yang, X.-H., Van Gele, M., Carling, T., Gu, J., Buyse, I. M., Fletcher, J. A., Liu, J., Bronson, R., et al. (2001) · Genes & Development · doi:10.1101/gad.870101 · Cited by 208 · cited 11×
“Abbreviations: ABC, activated B cell-like; ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; CLL, chronic lymphocytic leukemia; CLP, common lymphoid progenitor; CML, chronic myeloid leukemia; CMP, common myeloid progenitor; DLBCL, diffuse large B cell lymphoma; ES, embryonic stem; GC, germinal center; HA…”
BackgroundInfluentialSequence-specific regulator Prdm14 safeguards mouse ESCs from entering extraembryonic endoderm fates
Ma, Z., Swigut, T., Valouev, A., Rada-Iglesias, A., & Wysocka, J. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2000 · Cited by 204
Fears, S., Mathieu, C., Zeleznik-Le, N., Huang, S., Rowley, J. D., & Nucifora, G. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.4.1642 · Cited by 197 · cited 1×
“a naturally occurring splice variant where the splicing ofMDS1 to EVI1 generates a novel protein containing a PR domain [43].”
BackgroundCalado, D. P., Zhang, B., Srinivasan, L., Sasaki, Y., Seagal, J., Unitt, C., Rodig, S., Kutok, J., Tarakhovsky, A., Schmidt-Supprian, M., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.11.024 · Cited by 194 · cited 4×
“[65].”
BackgroundInfluentialDu, Y., Jenkins, N. A., & Copeland, N. G. (2005) · Blood · doi:10.1182/blood-2005-03-1113 · Cited by 189 · cited 1×
“The observations linking PRDM16 to tumorigenesis are remarkably similar to what was found for PRDM3, as Prdm16 also has been identified as a common viral integration site [78].”
ResultBuyse, I. M., Shao, G., & Huang, S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4467 · Cited by 189 · cited 2×
“PRDMs’ molecular mechanisms in transcriptional regulation Name Common alias HMT activity (in complex) Consensus sequence Binding partners PRDM1 BLIMP1 (Prmt5 H2AR3me2s, H4R3me2s [14]), (G9a H3K9me2 [9]) Yes [99] G9a [9], HDAC2 [13], IRF4 [100], LSD1 [15], PRMT5 [14], TLE1, TLE2 [18] PRDM2 RIZ1/2 H3K9me2 [6] ER [101],…”
EVI1 induces myelodysplastic syndrome in mice
Buonamici, S., Li, D., Chi, Y., Zhao, R., Wang, X., Brace, L., Ni, H., Saunthararajah, Y., & Nucifora, G. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21716 · Cited by 181 · cited 12×
“Abbreviations: ABC, activated B cell-like; ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; CLL, chronic lymphocytic leukemia; CLP, common lymphoid progenitor; CML, chronic myeloid leukemia; CMP, common myeloid progenitor; DLBCL, diffuse large B cell lymphoma; ES, embryonic stem; GC, germinal center; HA…”
BackgroundInfluentialCandidate tumor suppressor RIZ is frequently involved in colorectal carcinogenesis
Chadwick, R. B., Jiang, G.-L., Bennington, G. A., Yuan, B., Johnson, C. K., Stevens, M. W., Niemann, T. H., Peltomaki, P., Huang, S., & de la Chapelle, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040579497 · Cited by 174 · cited 1×
“Loss of functional PRDM2 has also been found in many types of solid tumors and in line with a tumor suppressive function, forced PRDM2 expression causes apoptosis and/or cell cycle arrest in cancer cell lines and suppresses growth in vivo [86, 87].”
BackgroundA role for Blimp1 in the transcriptional network controlling natural killer cell maturation
Kallies, A., Carotta, S., Huntington, N. D., Bernard, N. J., Tarlinton, D. M., Smyth, M. J., & Nutt, S. L. (2011) · Blood · doi:10.1182/blood-2010-08-303123 · Cited by 171 · cited 1×
“However, extensive research has revealed that PRDM1 is involved in differentiation, maintenance and/or function of multiple cell types, including hematopoietic cells from the myeloid lineage [55] and lymphoid lineages such as plasma cells [56], T-cells [57, 58], and NK cells [59] (Fig.”
BackgroundHuang, S., Shao, G., & Liu, L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.26.15933 · Cited by 165 · cited 1×
“PRDM2 RIZ1/2 H3K9me2 [6] ER [101], PRDM2 homodimer [102], RB1 [103]”
Hoyt, P. R., Bartholomew, C., Davis, A. J., Yutzey, K., Gamer, L. W., Potter, S. S., Ihle, J. N., & Mucenski, M. L. (1997) · Mechanisms of Development · doi:10.1016/s0925-4773(97)00057-9 · Cited by 164 · cited 2×
“5) [45] Insertion into Evi1 exon7 Prdm3/Evi1 Evi1 / and Tie2-Creþ; Evi1”
BackgroundWieser, R. (2007) · Gene · doi:10.1016/j.gene.2007.04.012 · Cited by 164
Histone methyltransferases, diet nutrients and tumour suppressors
Huang, S. (2002) · Nature reviews. Cancer · doi:10.1038/nrc819 · Cited by 151 · cited 4×
“Unlike the SET domain containing genes, PRDMs are not present in fungi and plant genomes, but originate in invertebrates [1, 4].”
BackgroundInfluentialBLIMP-1: trigger for differentiation of myeloid lineage
Chang, D., Angelin‐Duclos, C., & Calame, K. L. (2000) · Nature Immunology · doi:10.1038/77861 · Cited by 150 · cited 1×
“However, extensive research has revealed that PRDM1 is involved in differentiation, maintenance and/or function of multiple cell types, including hematopoietic cells from the myeloid lineage [55] and lymphoid lineages such as plasma cells [56], T-cells [57, 58], and NK cells [59] (Fig.”
BackgroundSu, S.-T., Ying, H.-Y., Chiu, Y.-K., Lin, F.-R., Chen, M.-Y., & Lin, K.-I. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01158-08 · Cited by 149 · cited 3×
“PRDMs’ molecular mechanisms in transcriptional regulation Name Common alias HMT activity (in complex) Consensus sequence Binding partners PRDM1 BLIMP1 (Prmt5 H2AR3me2s, H4R3me2s [14]), (G9a H3K9me2 [9]) Yes [99] G9a [9], HDAC2 [13], IRF4 [100], LSD1 [15], PRMT5 [14], TLE1, TLE2 [18] PRDM2 RIZ1/2 H3K9me2 [6] ER [101],…”
BackgroundEvi1 represses PTEN expression and activates PI3K/AKT/mTOR via interactions with polycomb proteins
Yoshimi, A., Goyama, S., Watanabe-Okochi, N., Yoshiki, Y., Nannya, Y., Nitta, E., Arai, S., Sato, T., Shimabe, M., Nakagawa, M., et al. (2011) · Blood · doi:10.1182/blood-2009-12-261602 · Cited by 146 · cited 8×
“Abbreviations: ABC, activated B cell-like; ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; CLL, chronic lymphocytic leukemia; CLP, common lymphoid progenitor; CML, chronic myeloid leukemia; CMP, common myeloid progenitor; DLBCL, diffuse large B cell lymphoma; ES, embryonic stem; GC, germinal center; HA…”
BackgroundInfluentialNishikata, I., Sasaki, H., Iga, M., Tateno, Y., Imayoshi, S., Asou, N., Nakamura, T., & Morishita, K. (2003) · Blood · doi:10.1182/blood-2002-12-3944 · Cited by 145 · cited 5×
“3, a chromosomal region subjected to reciprocal translocation in AML and MDS resulting in overexpression of PRDM16S [80].”
BackgroundInfluentialPrdm16 is a physiologic regulator of hematopoietic stem cells
Aguilo, F., Avagyan, S., Labar, A., Sevilla, A., Lee, D.-F., Kumar, P., Lemischka, I. R., Zhou, B. Y., & Snoeck, H.-W. (2011) · Blood · doi:10.1182/blood-2010-08-300145 · Cited by 143 · cited 2×
“Like Prdm3, mouse studies have shown that Prdm16 is required for HSC homeostasis [39, 52] and overexpression of Prdm16 causes a decrease of apoptosis and a relative increase of HSC number in vitro and increased reconstitution ability in vivo [53].”
BackgroundTrib1 and Evi1 cooperate with Hoxa and Meis1 in myeloid leukemogenesis
Jin, G., Yamazaki, Y., Takuwa, M., Takahara, T., Kaneko, K., Kuwata, T., Miyata, S., & Nakamura, T. (2007) · Blood · doi:10.1182/blood-2006-08-041202 · Cited by 143 · cited 11×
“Abbreviations: ABC, activated B cell-like; ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; CLL, chronic lymphocytic leukemia; CLP, common lymphoid progenitor; CML, chronic myeloid leukemia; CMP, common myeloid progenitor; DLBCL, diffuse large B cell lymphoma; ES, embryonic stem; GC, germinal center; HA…”
BackgroundInfluentialA Functional Screen to Identify Novel Effectors of Hematopoietic Stem Cell Activity
Deneault, É., Cellot, S., Faubert, A., Laverdure, J., Fréchette, M., Chagraoui, J., Mayotte, N., Sauvageau, M., Ting, S. B., & Sauvageau, G. (2009) · Cell · doi:10.1016/j.cell.2009.03.026 · Cited by 141
Watanabe, Y., Kim, H. S., Castoro, R. J., Chung, W., Estecio, M. R. H., Kondo, K., Guo, Y., Ahmed, S. S., Toyota, M., Itoh, F., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.02.085 · Cited by 139
Fumasoni, I., Meani, N., Rambaldi, D., Scafetta, G., Alcalay, M., & Ciccarelli, F. D. (2007) · BMC Evolutionary Biology · doi:10.1186/1471-2148-7-187 · Cited by 135 · cited 5×
“PRDMs’ molecular mechanisms in transcriptional regulation Name Common alias HMT activity (in complex) Consensus sequence Binding partners PRDM1 BLIMP1 (Prmt5 H2AR3me2s, H4R3me2s [14]), (G9a H3K9me2 [9]) Yes [99] G9a [9], HDAC2 [13], IRF4 [100], LSD1 [15], PRMT5 [14], TLE1, TLE2 [18] PRDM2 RIZ1/2 H3K9me2 [6] ER [101],…”
BackgroundInfluentialBurkitt Wright, E. M. M., Spencer, H. L., Daly, S. B., Manson, F. D. C., Zeef, L. A. H., Urquhart, J., Zoppi, N., Bonshek, R., Tosounidis, I., Mohan, M., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.05.007 · Cited by 135 · cited 1×
“Mechanistically, PRDM5 was suggested to act mainly as a transcriptional repressor [10] and to regulate genes involved in cell adhesion and extracellular matrix formation, along with several genes in the WNT pathway [93, 94].”
BackgroundDelwel, R., Funabiki, T., Kreider, B. L., Morishita, K., & Ihle, J. N. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.7.4291 · Cited by 131 · cited 1×
“[105, 106] BRG1 [107], CBP/p300 [108], CtBP [109],”
Davis, C. A., Haberland, M., Arnold, M. A., Sutherland, L. B., McDonald, O. G., Richardson, J. A., Childs, G., Harris, S., Owens, G. K., & Olson, E. N. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.7.2626-2636.2006 · Cited by 131 · cited 11×
“Abbreviations: ABC, activated B cell-like; ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; CLL, chronic lymphocytic leukemia; CLP, common lymphoid progenitor; CML, chronic myeloid leukemia; CMP, common myeloid progenitor; DLBCL, diffuse large B cell lymphoma; ES, embryonic stem; GC, germinal center; HA…”
BackgroundInfluentialGyöry, I., Fejér, G., Ghosh, N., Seto, E., & Wright, K. L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.6.3125 · Cited by 131 · cited 2×
“The function of the short PRDM1 isoform is still largely unknown, but may include alteration of repressive potential when compared to full-length PRDM1 [71].”
BackgroundKuo, T. C., & Calame, K. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5556 · Cited by 131 · cited 2×
“PRDMs’ molecular mechanisms in transcriptional regulation Name Common alias HMT activity (in complex) Consensus sequence Binding partners PRDM1 BLIMP1 (Prmt5 H2AR3me2s, H4R3me2s [14]), (G9a H3K9me2 [9]) Yes [99] G9a [9], HDAC2 [13], IRF4 [100], LSD1 [15], PRMT5 [14], TLE1, TLE2 [18] PRDM2 RIZ1/2 H3K9me2 [6] ER [101],…”
Chittka, A., & Chao, M. V. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10705 · Cited by 129 · cited 1×
“PRDM4 SC-1 p75 [120], HDAC1, HDAC2, HDAC3 [41]”
Gene Amplification and Overexpression of PRDM14 in Breast Cancers
Nishikawa, N., Toyota, M., Suzuki, H., Honma, T., Fujikane, T., Ohmura, T., Nishidate, T., Ohe-Toyota, M., Maruyama, R., Sonoda, T., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4111 · Cited by 129 · cited 1×
“Moreover, cell culture studies showed that overexpression of PRDM14 stimulated cell growth and collaborated with mutant RAS in the transformation of breast cancer cells, and also induced the expression of several breast cancer promoting genes [98].”
BackgroundGenome-Wide Survey and Developmental Expression Mapping of Zebrafish SET Domain-Containing Genes
Sun, X.-J., Xu, P.-F., Zhou, T., Hu, M., Fu, C.-T., Zhang, Y., Jin, Y., Chen, Y., Chen, S.-J., Huang, Q.-H., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001499 · Cited by 127 · cited 2×
“The expression pattern of PRDM proteins along mouse and zebrafish development is very dynamic as exemplified by expression of multiple PRDMs in the nervous system [3, 34].”
BackgroundThe Evi‐1 oncoprotein inhibits c‐Jun N‐terminal kinase and prevents stress‐induced cell death
Kurokawa, M., Mitani, K., Yamagata, T., Takahashi, T., Izutsu, K., Ogawa, S., Moriguchi, T., Nishida, E., Yazaki, Y., & Hirai, H. (2000) · The EMBO Journal · doi:10.1093/emboj/19.12.2958 · Cited by 124
Kinameri, E., Inoue, T., Aruga, J., Imayoshi, I., Kageyama, R., Shimogori, T., & Moore, A. W. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003859 · Cited by 121
Aberrant DNA hypermethylation signature in acute myeloid leukemia directed by EVI1
Lugthart, S., Figueroa, M. E., Bindels, E. M., Skrabanek, L. A., Valk, P. J. M., Li, Y., Meyer, S., Erpelinck-Verschueren, C. A. J., Greally, J. M., Löwenberg, B., et al. (2010) · Blood · doi:10.1182/blood-2010-04-281337 · Cited by 119 · cited 1×
“Dnmt3a/b [110, 111], GATA1 [49], HDAC1 [112],”
PRDM5 is silenced in human cancers and has growth suppressive activities
Deng, Q., & Huang, S. (2004) · Oncogene · doi:10.1038/sj.onc.1207615 · Cited by 110 · cited 2×
“PRDM5maps to human chromosome 4q26, a region associated with tumor suppression that is lost in several cancer types [89].”
BackgroundHernandez‐Lagunas, L., Choi, I. F., Kaji, T., Simpson, P. A., Hershey, C., Zhou, Y., Zon, L. I., Mercola, M. A., & Artinger, K. (2004) · Developmental Biology · doi:10.1016/j.ydbio.2004.11.014 · Cited by 110
PR-domain–containing Mds1-Evi1 is critical for long-term hematopoietic stem cell function
Zhang, Y., Stehling-Sun, S., Lezon-Geyda, K., Juneja, S. C., Coillard, L., Chatterjee, G., Wuertzer, C. A., Camargo, F., & Perkins, A. S. (2011) · Blood · doi:10.1182/blood-2011-02-334680 · Cited by 107 · cited 4×
“PRDM3 is a potential HMTase capable of regulating transcription by catalyzing histonemethylation, but no such activity has so far been detected [12].”
BackgroundInfluentialPRDM14 suppresses expression of differentiation marker genes in human embryonic stem cells
Tsuneyoshi, N., Sumi, T., Onda, H., Nojima, H., Nakatsuji, N., & Suemori, H. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.12.189 · Cited by 102 · cited 1×
“Since enzymatic activity of PRDM14 in ES cells has not been reported [21–23], it will be interesting to identify the different protein complexes which PRDM14 may recruit to either activate or repress transcription.”
BackgroundYoshida, M., Nosaka, K., Yasunaga, J.-I., Nishikata, I., Morishita, K., & Matsuoka, M. (2004) · Blood · doi:10.1182/blood-2003-07-2482 · Cited by 101 · cited 1×
“In support of the tumor suppressive function of the PR domain, full length PRDM16 decreases while PRDM16S increases the viability of adult T-cell leukemia cell lines treated with TGFb [82].”
BackgroundPRDM1/BLIMP-1 expression in multiple B and T-cell lymphoma.
García, J. F., Roncador, G., García, J.-F., Sanz, A., Maestre, L., Lucas, E., Montes‐Moreno, S., Victoria, R. F., Martinez-Torrecuadrara, J. L., Marafioti, T., et al. (2006) · PubMed · Cited by 98
Evi-1 Transforming and Repressor Activities Are Mediated by CtBP Co-repressor Proteins
Palmer, S., Brouillet, J.-P., Kilbey, A., Fulton, R., Walker, M., Crossley, M., & Bartholomew, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102343200 · Cited by 97 · cited 4×
“[105, 106] BRG1 [107], CBP/p300 [108], CtBP [109],”
InfluentialRepression of Bone Morphogenetic Protein and Activin-inducible Transcription by Evi-1
Alliston, T., Ko, T. C., Cao, Y., Liang, Y.-Y., Feng, X.-H., Chang, C., & Derynck, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414305200 · Cited by 96 · cited 1×
“SMAD1/2 [117], SMAD3 [118], SUV39H1 [104],”
Funabiki, T., Bl, K., & Ihle, J. N. (1994) · PubMed · Cited by 92
Duan, Z., Person, R. E., Lee, H.-H., Huang, S., Donadieu, J., Badolato, R., Grimes, H. L., Papayannopoulou, T., & Horwitz, M. S. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00762-07 · Cited by 91 · cited 15×
“PRDMs’ molecular mechanisms in transcriptional regulation Name Common alias HMT activity (in complex) Consensus sequence Binding partners PRDM1 BLIMP1 (Prmt5 H2AR3me2s, H4R3me2s [14]), (G9a H3K9me2 [9]) Yes [99] G9a [9], HDAC2 [13], IRF4 [100], LSD1 [15], PRMT5 [14], TLE1, TLE2 [18] PRDM2 RIZ1/2 H3K9me2 [6] ER [101],…”
BackgroundInfluentialChakraborty, S., Senyuk, V., Sitailo, S., Chi, Y., & Nucifora, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106733200 · Cited by 90 · cited 2×
“[105, 106] BRG1 [107], CBP/p300 [108], CtBP [109],”
PRDM5 Identified as a Target of Epigenetic Silencing in Colorectal and Gastric Cancer
Watanabe, Y., Toyota, M., Kondo, Y., Suzuki, H., Imai, T., Ohe-Toyota, M., Maruyama, R., Nojima, M., Sasaki, Y., Sekido, Y., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0305 · Cited by 89 · cited 1×
“Epigenetic silencing of the PRDM5 promoter has been found in several different cancer cell lines and clinical samples from different tissue origins including breast, liver, ovary, cervix and the gastrointestinal tract [89–91].”
BackgroundEvi-1 is a transcriptional target of mixed-lineage leukemia oncoproteins in hematopoietic stem cells
Arai, S., Yoshimi, A., Shimabe, M., Ichikawa, M., Nakagawa, M. M., Imai, Y., Goyama, S., & Kurokawa, M. (2010) · Blood · doi:10.1182/blood-2009-07-234310 · Cited by 88 · cited 1×
“Recently, EVI1 was shown to be a transcriptional target gene for leukemia-associated fusion oncoproteins, thus providing a mechanism for EVI1 upregulation in leukemias without 3q26 translocations [74].”
BackgroundSKI and MEL1 Cooperate to Inhibit Transforming Growth Factor-β Signal in Gastric Cancer Cells
Takahata, M., Inoue, Y., Tsuda, H., Imoto, I., Koinuma, D., Hayashi, M., Ichikura, T., Yamori, T., Nagasaki, K., Yoshida, M., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808989200 · Cited by 87 · cited 1×
“PPARa, PPARg [20], SKI [121], Smad3 [122]”
Histone methyltransferase PRDM8 regulates mouse testis steroidogenesis
Eom, G. H., Kim, K., Kim, S., Kee, H. J., Kim, J., Jin, H. M., Kim, J.-R., Kim, J. H., Choe, N., Kim, K., et al. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.134 · Cited by 80 · cited 1×
“Recombinant PRDM2 and PRDM8 were both shown to act as repressive HMTases by catalyzing di-methylation of lysine 9 of histone H3 (H3K9me2) [6, 7], while PRDM9 was found to catalyze the activating histone mark tri-methylated lysine 4 of histone H3 (H3K4me3) [8].”
BackgroundEVI1 Impairs Myelopoiesis by Deregulation of PU.1 Function
Laricchia-Robbio, L., Premanand, K., Rinaldi, C. R., & Nucifora, G. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2562 · Cited by 73 · cited 2×
“1 [50]”
A Histone Methyltransferase Is Required for Maximal Response to Female Sex Hormones
Carling, T., Kim, K.-C., Yang, X.-H., Gu, J., Zhang, X.-K., & Huang, S. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7032-7042.2004 · Cited by 72 · cited 1×
“Regarding breast cancer, PRDM2 acts as a co-activator of the estrogen receptor by recruiting HATs to the promoter of estrogen receptor target genes [88], but whether this function of PRDM2 is involved in breast cancer is unknown.”
BackgroundChittka, A., Arevalo, J. C., Rodriguez-Guzman, M., Pérez, P., Chao, M. V., & Sendtner, M. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200301106 · Cited by 71 · cited 5×
“Thus, PRDM4 may be involved in NGF signaling in vitro, but the function of PRDM4 has not been addressed in vivo.”
BackgroundInfluentialOverexpression of sPRDM16 coupled with loss of p53 induces myeloid leukemias in mice
Shing, D. C., Trubia, M., Marchesi, F., Radaelli, E., Belloni, E., Tapinassi, C., Scanziani, E., Mecucci, C., Crescenzi, B., Lahortiga, I., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32390 · Cited by 67 · cited 1×
“In fact, PRDM16 is also called MDS1/EVI1-like gene 1 (MEL1) and, like PRDM3, is expressed in a long (PRDM16L/MEL1L) and a short oncogenic form lacking the PR domain (PRDM16S/ MEL1S); the latter is capable of inducing myeloid leukemia in p53 KO mice [79].”
BackgroundLaricchia-Robbio, L., Fazzina, R., Li, D., Rinaldi, C. R., Sinha, K. K., Chakraborty, S., & Nucifora, G. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00363-06 · Cited by 66 · cited 2×
“Dnmt3a/b [110, 111], GATA1 [49], HDAC1 [112],”
Dettman, E. J., Simko, S. J., Ayanga, B. A., Carofino, B. L., Margolin, J., Morse, H. C., & Justice, M. J. (2011) · Oncogene · doi:10.1038/onc.2011.12 · Cited by 65 · cited 4×
“Interestingly, Prdm14-induced leuke- Bioessays 34: 50–60, 2011 WILEY Periodicals, Inc. 57 R e v ie w e s s a y s mia is more often found in female mice compared to males: this may be related to the Prdm14-mediated upregulation of the estrogen-dependent oncogene Myb [97].”
BackgroundInfluentialRepression of RUNX1 Activity by EVI1: A New Role of EVI1 in Leukemogenesis
Senyuk, V., Sinha, K. K., Li, D., Rinaldi, C. R., Yanamandra, S., & Nucifora, G. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3962 · Cited by 64 · cited 3×
“PRDMs’ molecular mechanisms in transcriptional regulation Name Common alias HMT activity (in complex) Consensus sequence Binding partners PRDM1 BLIMP1 (Prmt5 H2AR3me2s, H4R3me2s [14]), (G9a H3K9me2 [9]) Yes [99] G9a [9], HDAC2 [13], IRF4 [100], LSD1 [15], PRMT5 [14], TLE1, TLE2 [18] PRDM2 RIZ1/2 H3K9me2 [6] ER [101],…”
Vinatzer, U., Taplick, J., Seiser, C., Fonatsch, C., & Wieser, R. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02987.x · Cited by 64 · cited 3×
“Dnmt3a/b [110, 111], GATA1 [49], HDAC1 [112],”
Nie, K., Zhang, T., Allawi, H. T., Gomez, M. F., Liu, Y., Chadburn, A., Wang, Y. L., Knowles, D. M., & Tam, W. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.091291 · Cited by 60
Jiang, G., & Huang, S. (2001) · PubMed · Cited by 60
Pastural, É., Takahashi, N., Dong, W.-F., Bainbridge, M. N., Hull, A. R., Pearson, D., Huang, S., Lowsky, R., DeCoteau, J. F., & Geyer, C. R. (2006) · Oncogene · doi:10.1038/sj.onc.1209959 · Cited by 58 · cited 1×
“In CML blast crisis cell lines, PRDM2 overexpression induces apoptosis and enhances differentiation possibly involving repression of the IGF1 promoter by H3K9 histone methylation [85].”
BackgroundSenyuk, V. I., Premanand, K., Xu, P., Qian, Z., & Nucifora, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020793 · Cited by 56 · cited 1×
“Dnmt3a/b [110, 111], GATA1 [49], HDAC1 [112],”
Cuenco, G. M., & Ren, R. (2004) · Oncogene · doi:10.1038/sj.onc.1207143 · Cited by 55 · cited 16×
“Studies of murine Evi1-overexpressing bone-marrow transplantations have shown different results ranging from lowpenetrant lymphoid/myeloid malignancies [51] to MDS [48, 75] or AML [76].”
BackgroundInfluentialEVI1 recruits the histone methyltransferase SUV39H1 for transcription repression
Cattaneo, F., & Nucifora, G. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21869 · Cited by 54 · cited 3×
“PRDMs’ molecular mechanisms in transcriptional regulation Name Common alias HMT activity (in complex) Consensus sequence Binding partners PRDM1 BLIMP1 (Prmt5 H2AR3me2s, H4R3me2s [14]), (G9a H3K9me2 [9]) Yes [99] G9a [9], HDAC2 [13], IRF4 [100], LSD1 [15], PRMT5 [14], TLE1, TLE2 [18] PRDM2 RIZ1/2 H3K9me2 [6] ER [101],…”
Behrends, U., Schneider, I., Rössler, S., Frauenknecht, H., Golbeck, A., Lechner, B., Eigenstetter, G., Zobywalski, C., Müller‐Weihrich, S., Graubner, U., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11208 · Cited by 54 · cited 1×
“Interestingly, PRDM13 was identified as a tumor antigen of medulloblastoma, a brain tumor malignancy deriving from embryonal cells of neuroectodermal origin [38].”
BackgroundWu, Y., Ferguson, J. E., Wang, H., Kelley, R., Ren, R., McDonough, H., Meeker, J., Charles, P. C., Wang, H., & Patterson, C. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2007.06.008 · Cited by 52 · cited 4×
“A PRDM6 isoform containing an additional 170 amino acids was later described to promote early vascular differentiation by inhibiting endothelial differentiation [16].”
BackgroundInfluentialPRDM16/MEL1: A novel Smad binding protein expressed in murine embryonic orofacial tissue
Warner, D. R., Horn, K. H., Mudd, L., Webb, C. L., Greene, R. M., & Pisano, M. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.03.016 · Cited by 49 · cited 2×
“PRDMs’ molecular mechanisms in transcriptional regulation Name Common alias HMT activity (in complex) Consensus sequence Binding partners PRDM1 BLIMP1 (Prmt5 H2AR3me2s, H4R3me2s [14]), (G9a H3K9me2 [9]) Yes [99] G9a [9], HDAC2 [13], IRF4 [100], LSD1 [15], PRMT5 [14], TLE1, TLE2 [18] PRDM2 RIZ1/2 H3K9me2 [6] ER [101],…”
Yang, X. H., & Huang, S. (1999) · Genomics · doi:10.1006/geno.1999.5967 · Cited by 49
Dettman, E. J., & Justice, M. J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003823 · Cited by 49
Stage-Specific Modulation of IFN-Regulatory Factor 4 Function by Krüppel-Type Zinc Finger Proteins
Gupta, S., Anthony, A., & Pernis, A. B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.10.6104 · Cited by 49 · cited 2×
“PRDMs’ molecular mechanisms in transcriptional regulation Name Common alias HMT activity (in complex) Consensus sequence Binding partners PRDM1 BLIMP1 (Prmt5 H2AR3me2s, H4R3me2s [14]), (G9a H3K9me2 [9]) Yes [99] G9a [9], HDAC2 [13], IRF4 [100], LSD1 [15], PRMT5 [14], TLE1, TLE2 [18] PRDM2 RIZ1/2 H3K9me2 [6] ER [101],…”
Erythroid defects and increased retrovirally-induced tumor formation in Evi1 transgenic mice
Louz, D., Broek, M. V. D., Verbakel, S. E., Vankan, Y., van Lom, K., Joosten, M., Meijer, D., Löwenberg, B., & Delwel, R. (2000) · Leukemia · doi:10.1038/sj.leu.2401887 · Cited by 48 · cited 2×
“Surprisingly, without insertional mutagenesis, Evi1 overexpression in transgenic mice does not induce hematological malignancies [77].”
BackgroundThe Tumor Suppressor PRDM5 Regulates Wnt Signaling at Early Stages of Zebrafish Development
Meani, N., Pezzimenti, F., Deflorian, G., Mione, M., & Alcalay, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004273 · Cited by 47 · cited 2×
“Mechanistically, PRDM5 was suggested to act mainly as a transcriptional repressor [10] and to regulate genes involved in cell adhesion and extracellular matrix formation, along with several genes in the WNT pathway [93, 94].”
BackgroundChi, Y., Senyuk, V. I., Chakraborty, S., & Nucifora, G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309645200 · Cited by 44 · cited 2×
“[105, 106] BRG1 [107], CBP/p300 [108], CtBP [109],”
Significant increase of self-renewal in hematopoietic cells after forced expression of EVI1
Laricchia‐Robbio, L., & Nucifora, G. (2007) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2007.07.012 · Cited by 40
Expression of the mouse PR domain protein Prdm8 in the developing central nervous system
Komai, T., Iwanari, H., Mochizuki, Y., Hamakubo, T., & Shinkai, Y. (2009) · Gene Expression Patterns · doi:10.1016/j.gep.2009.07.005 · Cited by 38 · cited 1×
“In addition, the expression of Prdm8 and Prdm10 in the mouse embryo nervous system has been characterized in detail [36, 37].”
BackgroundMedici, N., Abbondanza, C., Nigro, V., Rossi, V., Piluso, G., Belsito, A., Gallo, L., Roscigno, A., Bontempo, P., Puca, A. A., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1604 · Cited by 33 · cited 1×
“PRDM2 RIZ1/2 H3K9me2 [6] ER [101], PRDM2 homodimer [102], RB1 [103]”
RIZ1 is potential CML tumor suppressor that is down-regulated during disease progression
Lakshmikuttyamma, A., Takahashi, N., Pastural, É., Torlakovic, E., Amin, H. M., Garcia‐Manero, G., Voralia, M., Czader, M., DeCoteau, J. F., & Geyer, C. R. (2009) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-2-28 · Cited by 28 · cited 6×
“Abbreviations: ABC, activated B cell-like; ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; CLL, chronic lymphocytic leukemia; CLP, common lymphoid progenitor; CML, chronic myeloid leukemia; CMP, common myeloid progenitor; DLBCL, diffuse large B cell lymphoma; ES, embryonic stem; GC, germinal center; HA…”
BackgroundInfluentialExpression patterns of PRDM10 during mouse embryonic development
Park, J.-A., & Kim, K.-C. (2010) · BMB Reports · doi:10.5483/bmbrep.2010.43.1.029 · Cited by 27
Shimahara, A., Yamakawa, N., Nishikata, I., & Morishita, K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.102046 · Cited by 26
DNA methylation and carcinogenesis of PRDM5 in cervical cancer
Cheng, H.-Y., Chen, X.-W., Cheng, L., Liu, Y.-D., & Lou, G. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0840-9 · Cited by 25 · cited 1×
“Epigenetic silencing of the PRDM5 promoter has been found in several different cancer cell lines and clinical samples from different tissue origins including breast, liver, ovary, cervix and the gastrointestinal tract [89–91].”
BackgroundUXT interacts with the transcriptional repressor protein EVI1 and suppresses cell transformation
McGilvray, R. W., Walker, M., & Bartholomew, C. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.05928.x · Cited by 24 · cited 1×
“UXT [119], Polycomb complexes [76], Pu.”
Nishikata, I., Nakahata, S., Saito, Y., Kaneda‐Nakashima, K., Ichihara, E., Yamakawa, N., & Morishita, K. (2011) · Oncogene · doi:10.1038/onc.2011.132 · Cited by 24 · cited 3×
“PRDMs’ molecular mechanisms in transcriptional regulation Name Common alias HMT activity (in complex) Consensus sequence Binding partners PRDM1 BLIMP1 (Prmt5 H2AR3me2s, H4R3me2s [14]), (G9a H3K9me2 [9]) Yes [99] G9a [9], HDAC2 [13], IRF4 [100], LSD1 [15], PRMT5 [14], TLE1, TLE2 [18] PRDM2 RIZ1/2 H3K9me2 [6] ER [101],…”
BackgroundBlimp1 is limiting for transformation in a mouse plasmacytoma model
D’Costa, K., Emslie, D., Metcalf, D., Smyth, G. K., Karnowski, A., Kallies, A., Nutt, S. L., & Corcoran, L. M. (2009) · Blood · doi:10.1182/blood-2008-08-172866 · Cited by 22 · cited 2×
“Peculiarly, PRDM1 may be oncogenic in tumors arising from plasma cells (plasmacytomas) in mice and humans [69, 70] suggesting a critical role for PRDM1 in transformation of antibody-secreting cells by a yet unidentified mechanism.”
BackgroundSpensberger, D., Vermeulen, M., Le Guezennec, X., Beekman, R., van Hoven, A., Bindels, E., Stunnenberg, H., & Delwel, R. (2008) · Biochemistry · doi:10.1021/bi800267f · Cited by 22 · cited 2×
“PRDMs’ molecular mechanisms in transcriptional regulation Name Common alias HMT activity (in complex) Consensus sequence Binding partners PRDM1 BLIMP1 (Prmt5 H2AR3me2s, H4R3me2s [14]), (G9a H3K9me2 [9]) Yes [99] G9a [9], HDAC2 [13], IRF4 [100], LSD1 [15], PRMT5 [14], TLE1, TLE2 [18] PRDM2 RIZ1/2 H3K9me2 [6] ER [101],…”
Leung, K. N., Mak, N. K., & Fung, M. C. (2005) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360500295154 · Cited by 19 · cited 1×
“CML is a progressive disease with a terminal phase called blast crisis, which, like AML, is characterized by uncontrolled cell proliferation and a block in myeloid differentiation [62].”
BackgroundZhang, Y., Xie, H.-Q., Chen, Y., Jiao, B., Shen, Z., Chen, S., & Zhao, W. (2010) · International Journal of Hematology · doi:10.1007/s12185-010-0689-3 · Cited by 15
The PR/SET domain in PRDM4 is preceded by a zinc knuckle
Briknarová, K., Atwater, D. Z., Glicken, J. M., Maynard, S. J., & Ness, T. E. (2011) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.23057 · Cited by 10
Cited by
DNA methylation in newborns and maternal smoking in pregnancy: genome-wide consortium meta-analysis
Joubert, B. R., Felix, J. F., Yousefi, P., Bakulski, K. M., Just, A. C., Breton, C., Reese, S. E., Markunas, C. A., Richmond, R. C., Xu, C.-J., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.02.019 · Cited by 886
“PRDM8 is one of several PRDMs belonging to the SET domain family of histone methyltransferases.(64) PRDM genes either act as direct histone methyltransferases or recruit a suite of histone-modifying enzymes to target promoters.”
Meiotic recombination in mammals: localization and regulation
Baudat, F., Imai, Y., & de Massy, B. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3573 · Cited by 583
Histone lysine methyltransferases in biology and disease
Husmann, D., & Gozani, O. (2019) · Nature Structural & Molecular Biology · doi:10.1038/s41594-019-0298-7 · Cited by 464
Specification and epigenetic programming of the human germ line
Tang, W. W. C., Kobayashi, T., Irie, N., Dietmann, S., & Surani, M. A. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.88 · Cited by 456
Initiation of Meiotic Recombination: How and Where? Conservation and Specificities Among Eukaryotes
de Massy, B. (2013) · Annual Review of Genetics · doi:10.1146/annurev-genet-110711-155423 · Cited by 397
Metadata
- Authors
- Fog, C. K., Galli, G. G., & Lund, A. H.
- Affiliations
- University of Copenhagen (DK)
- Corresponding author
- Lund, Anders H.
- Venue
- BioEssays
- Publisher
- Wiley
- Published
- 2011-10-26
- Volume
- 34
- Issue
- 1
- Pages
- 50-60
- ISSN
- 0265-9247 (ISSN-L)
- 1521-1878
- OpenAlex
- W2078485482
- Cited by
- 201
- References
- 123
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 11 · 2023: 12 · 2022: 9 · 2021: 14 · 2020: 18 · 2019: 19 · 2018: 10 · 2017: 14 · 2016: 18 · 2015: 23 · 2014: 12 · 2013: 21 · 2012: 6
- FWCI
- 1.13
- Type
- journal article
- Language
- en
- Open access
- green
- zenodo.org
- Licence
- Locations
- BioEssays (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, other-oa)
- Funders
- Lundbeckfonden
- Novo Nordisk Fonden
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer-related gene regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- cell differentiation, hematologic malignancies, solid tumors, tumor suppressor, functional redundancy, protein complexes
- MeSH terms
- Animals, Blood Vessels, Adipose Tissue, Brown, Cell Differentiation, Gene Expression Regulation, Hematopoiesis, Histones, Humans, Isoenzymes, Methylation, Mice, Transgenic, Neoplasms, Organ Specificity, Protein Methyltransferases, Transcription, Genetic, Signal Transduction, Hematologic Neoplasms, Tumor Suppressor Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.